Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC

Clinical trial NCT04973306 · RECRUITING

Trial details

NCT number: NCT04973306
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma Stage II Esophageal Squamous Cell Carcinoma Stage III

Start date: 2022-03-02
Primary completion: 2024-07-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.